FDA approves Vyleesi for use in premenopausal women with libido
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
HSDD is one of the most common sexual dysfunctions among women, affecting about 6 million premenopausal women in the United StatesHSDD is characterized by decreased libido, accompanied by stress, which often affects a woman's emotionaland health(http://, intimacy and overall quality of liferecently, the u.SFDA(http://announced the approval of AMAG Pharmaceuticals(http://and Palatin Technologies, a joint development of Vymelanotide, to treat premenopausal women's libido (HSDD)VyleesiVyleesi is a "first-in-class" innovation of the Black Skin 4 receptor (melanocortin 4 receptor, MC4R)Thisnew drug(http://can be used with an auto-disposable syringe prior to the expected sexual activity, which is not required daily use by Patients with HSDD FDA approval is based on Vyleesi's performance in a Phase 3 clinical study project called RECONNECT The study included two randomized double-blind, placebo-controlled phase 3 clinical trial series (http:// , which included a total of 1,247 premenopausal patients results showed that both trials reached the common primary endpoint of the trial, with a significant lying 25 percent of women receiving a libido index, significantly better than the placebo group (17 percent) At the same time, Vyleesi reduces anxiety caused by HSDD
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
